GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

1

GLP-1 receptor agonists (RAs) are linked to higher odds of nonscarring hair loss in adults compared to matched controls.
2

At 6 months, GLP-1 RA users had 1.62 times the odds of androgenetic alopecia and 1.26 times the odds of overall nonscarring hair loss.
3

By 12 months, the odds increased to 1.76 for telogen effluvium, 1.64 for androgenetic alopecia, and 1.40 for overall nonscarring hair loss.
4

The study highlights a rising incidence of nonscarring hair loss among GLP-1 RA users from 2014 to 2024, diverging trends noted from 2019.
5

Researchers emphasize the need for awareness of alopecia risk in GLP-1 RA patients for early detection and call for further research.

1